Uveitis reactivation following recombinant zoster vaccination

PURPOSE: Describe three cases of uveitis reactivation following immunization with recombinant zoster vaccine (RZV). OBSERVATIONS: One patient developed reactivation of previously controlled multifocal choroiditis within one week of receiving RZV, requiring treatment with systemic corticosteroids. Tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Richards, Paige J., Wingelaar, Maxwell J., Armbrust, Karen R., Kopplin, Laura J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141504/
https://www.ncbi.nlm.nih.gov/pubmed/34041415
http://dx.doi.org/10.1016/j.ajoc.2021.101115
_version_ 1783696376481185792
author Richards, Paige J.
Wingelaar, Maxwell J.
Armbrust, Karen R.
Kopplin, Laura J.
author_facet Richards, Paige J.
Wingelaar, Maxwell J.
Armbrust, Karen R.
Kopplin, Laura J.
author_sort Richards, Paige J.
collection PubMed
description PURPOSE: Describe three cases of uveitis reactivation following immunization with recombinant zoster vaccine (RZV). OBSERVATIONS: One patient developed reactivation of previously controlled multifocal choroiditis within one week of receiving RZV, requiring treatment with systemic corticosteroids. Two patients with previously controlled anterior uveitis developed new anterior segment inflammation after RZV; both were treated with topical corticosteroids and systemic antiviral therapy. CONCLUSION AND IMPORTANCE: Uveitis recurrence is an infrequent but serious potential ocular side effect of recombinant zoster vaccination.
format Online
Article
Text
id pubmed-8141504
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81415042021-05-25 Uveitis reactivation following recombinant zoster vaccination Richards, Paige J. Wingelaar, Maxwell J. Armbrust, Karen R. Kopplin, Laura J. Am J Ophthalmol Case Rep Case Report PURPOSE: Describe three cases of uveitis reactivation following immunization with recombinant zoster vaccine (RZV). OBSERVATIONS: One patient developed reactivation of previously controlled multifocal choroiditis within one week of receiving RZV, requiring treatment with systemic corticosteroids. Two patients with previously controlled anterior uveitis developed new anterior segment inflammation after RZV; both were treated with topical corticosteroids and systemic antiviral therapy. CONCLUSION AND IMPORTANCE: Uveitis recurrence is an infrequent but serious potential ocular side effect of recombinant zoster vaccination. Elsevier 2021-05-03 /pmc/articles/PMC8141504/ /pubmed/34041415 http://dx.doi.org/10.1016/j.ajoc.2021.101115 Text en © 2021 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Richards, Paige J.
Wingelaar, Maxwell J.
Armbrust, Karen R.
Kopplin, Laura J.
Uveitis reactivation following recombinant zoster vaccination
title Uveitis reactivation following recombinant zoster vaccination
title_full Uveitis reactivation following recombinant zoster vaccination
title_fullStr Uveitis reactivation following recombinant zoster vaccination
title_full_unstemmed Uveitis reactivation following recombinant zoster vaccination
title_short Uveitis reactivation following recombinant zoster vaccination
title_sort uveitis reactivation following recombinant zoster vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141504/
https://www.ncbi.nlm.nih.gov/pubmed/34041415
http://dx.doi.org/10.1016/j.ajoc.2021.101115
work_keys_str_mv AT richardspaigej uveitisreactivationfollowingrecombinantzostervaccination
AT wingelaarmaxwellj uveitisreactivationfollowingrecombinantzostervaccination
AT armbrustkarenr uveitisreactivationfollowingrecombinantzostervaccination
AT kopplinlauraj uveitisreactivationfollowingrecombinantzostervaccination

Ejemplares similares